Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06008457 · ClinicalTrials.gov registry record
Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit
A clinical trial, sponsored by Sequenom.
- Completed
- Registry status
- 1,600
- Enrollment target
NCT06008457 is a clinical trial that has completed, run by Sequenom. The registered enrollment target is 1,600 participants.
The verdict
NCT06008457 has completed, sponsored by Sequenom.
- COMPLETED
- Registry status
- 1,600 participants
- Enrollment target
Study Summary
To compare the results obtained by analysis of a self-collected anterior nasal (AN) swab as part of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit to a healthcare provider (HCP)-collected AN swab in patients with symptoms of viral respiratory infection consistent with influenza A (Flu A), influenza B (Flu B), respiratory syncytial virus (RSV) and/or SARS-CoV-2 (C-19).
Interventions
- DEVICE Labcorp COVID-19+Flu+RSV Test Home Collection Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2023-04-17 |
| Est. Completion | 2025-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06008457
The ClinicalTrials.gov registry entry for NCT06008457 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sequenom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Labcorp COVID-19+Flu+RSV Test Home Collection Kit is the first listed.
NCT06008457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06008457 about?
NCT06008457 is a clinical study titled "Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit". To compare the results obtained by analysis of a self-collected anterior nasal (AN) swab as part of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit to a healthcare provider (HCP)-collected AN swab in patients with symptoms of viral respiratory infection consistent with influenza A (Flu A), inf...
What is the current status of trial NCT06008457?
This trial is currently completed. The enrollment target is 1,600 participants. The study started on 2023-04-17. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT06008457?
The interventions under investigation include: Labcorp COVID-19+Flu+RSV Test Home Collection Kit (DEVICE).
Who is sponsoring clinical trial NCT06008457?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.